Cebranopadol - CAS# 863513-91-1 suquidar Disparate effects of thrombin receptor

Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats

is a semi-synthetic erythromycin derivative used to treat mild to moderate respiratory infections

5-1(3(7)8)2(6)4(9)10/h8-10

CAS Number: 108852-90-0

56(9):1435-50

Cebranopadol - CAS# 863513-91-1 suquidar Disparate effects of thrombin receptorCebranopadol, also known as GRT 6005, is a Opioid Receptor Agonist with agonistic activity at nociceptin orphanin FQ and opioid receptors. Cebranopadol displays analgesic, antiallodynic and antihyperalgesic properties in several rat models of acute nociceptive, inflammatory, cancer and neuropathic pain. In contrast to classical opioids, it has a higher analgesic potency in models of neuropathic pain than in acute nociceptive pain. Even at higher